Skip to main content

Table 2 Fluid balance of patients included in the study according to treatment group

From: The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study

Fluid balance All patients
(n = 124)
NacA group
(n = 60)
Control group
(n = 64)
P value
Before (2 days) contrast infusion 1145.6 (178.2) 1000.9 (266.3) 1269.0 (244.2) 0.46
Before (1 day) contrast infusion 1399.7 (151.0) 1117.5 (198.4) 1655.9 (225.3) 0.08
Day of contrast infusion 1463.6 (159.4) 1133 (194.8) 1633.4 (227.6) 0.09
First day after contrast infusion 1310.4 (167.1) 1317.1 (256.4) 1306.3 (224.3) 0.97
Second day after contrast infusion 996.1 (137.6) 1095.6 (237.8) 945.3 (163.0) 0.59
Third day after contrast infusion 844.9 (174.2) 902.9 (298.2) 774.4 (195.8) 0.71
Fourth day after contrast infusion 869.8 (167.4) 1042.5 (241.2) 691.9 (236.8) 0.30
Fifth day after contrast infusion 897.6 (235.5) 870.3 (340.3) 967.4 (234.3) 0.70
  1. Data presented as mean (SE)
  2. NacA group Treatment (N-acetylcysteine and ascorbic acid) group